BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35245565)

  • 1. Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients.
    Iorizzo M; Starace M; Vano-Galvan S; Piraccini BM; Reygagne P; Rudnicka L; Silyuk T; Sinclair R; Tosti A
    J Am Acad Dermatol; 2022 Sep; 87(3):666-669. PubMed ID: 35245565
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
    Pimenta R; Borges-Costa J
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):49-50. PubMed ID: 31032795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory folliculitis decalvans treated with biologics: Case series in 4 situations.
    Lobato-Berezo A; Pujol RM
    Dermatol Ther; 2022 Oct; 35(10):e15778. PubMed ID: 35988046
    [No Abstract]   [Full Text] [Related]  

  • 4. Folliculitis decalvans-like pustular plaques on the limbs sparing the scalp.
    Yang A; Hannaford R; Kossard S
    Australas J Dermatol; 2020 Feb; 61(1):54-56. PubMed ID: 31621894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study.
    Dupont A; Eyraud A; Milpied B; De Bataille S; Cassassa E; Darrigade AS; Barnetche T; Doutre MS; Matard B; Beylot-Barry M; Seneschal J
    Acta Derm Venereol; 2023 Mar; 103():adv3713. PubMed ID: 36987539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folliculitis decalvans managed with adalimumab: A case report.
    Alsantali A; Baghdadi R; Alghamdi Y; Abbas EB; Ghazi R
    Clin Case Rep; 2023 Dec; 11(12):e8193. PubMed ID: 38076009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous human immunoglobulin for treatment of folliculitis decalvans.
    Ismail N; Ralph N; Murphy G
    J Dermatolog Treat; 2015 Oct; 26(5):471-2. PubMed ID: 25798695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminolevulinic acid photodynamic therapy for folliculitis decalvans: A case report.
    Lin X; Zhou S; Wang X; Zhu X
    Dermatol Ther; 2020 May; 33(3):e13358. PubMed ID: 32233085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dapsone treatment of folliculitis decalvans].
    Paquet P; Piérard GE
    Ann Dermatol Venereol; 2004 Feb; 131(2):195-7. PubMed ID: 15026749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cicatricial alopecia: Other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias.
    Bolduc C; Sperling LC; Shapiro J
    J Am Acad Dermatol; 2016 Dec; 75(6):1101-1117. PubMed ID: 27846945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
    Zamperetti M; Zelger B; Höpfl R
    Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary scarring alopecias.
    Rigopoulos D; Stamatios G; Ioannides D
    Curr Probl Dermatol; 2015; 47():76-86. PubMed ID: 26370646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for the treatment of folliculitis decalvans.
    Castaño-Suárez E; Romero-Maté A; Arias-Palomo D; Borbujo J
    Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):102-4. PubMed ID: 22409714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab for interleukin-1β-mediated chronic non-scarring scalp folliculitis: Case report and literature review.
    Soglia S; Maione V; Bugatti M; Vermi W; Calzavara-Pinton P; Venturini M
    J Dermatol; 2022 Jan; 49(1):157-160. PubMed ID: 34472127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.
    Uchiyama M; Harada K; Tobita R; Irisawa R; Tsuboi R
    J Am Acad Dermatol; 2021 Nov; 85(5):1185-1193. PubMed ID: 32272176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-Recalcitrant Folliculitis Decalvans Controlled Successfully with Adalimumab.
    Alhameedy MM; Alsantali AM
    Int J Trichology; 2019; 11(6):241-243. PubMed ID: 32030059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
    Nowaczyk J; Fret K; Kaminska-Winciorek G; Rudnicka L; Czuwara J
    Anticancer Drugs; 2023 Sep; 34(8):942-948. PubMed ID: 36708507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinea capitis mimicking tufted hair folliculitis.
    Baroni A; Ruocco E; Aiello FS; Faccenda F; Lo Schiavo A; Satriano RA; Guerrera V
    Clin Exp Dermatol; 2009 Dec; 34(8):e699-701. PubMed ID: 19663859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of folliculitis decalvans with medical honey.
    Yeh JE; Hartman RI; Xu J; Hoang M; Yasuda MR
    Dermatol Online J; 2019 Aug; 25(8):. PubMed ID: 31553869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy should be considered for the treatment of folliculitis decalvans.
    Yang L; Chen J; Tong X; Gao L; Ding S; Guo A
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102356. PubMed ID: 34048971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.